"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about DOXORUBICIN
• Ask Community about DOXORUBICIN
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

DOXORUBICIN Safety Questions, DOXORUBICIN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about DOXORUBICIN. Our extensive database of DOXORUBICIN adverse events and DOXORUBICIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about DOXORUBICIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

DOXORUBICIN Safety Reports

Total DOXORUBICIN reports: 257.
DOXORUBICIN FDA safety alerts: No.
Reported deaths: 51    Reported hospitalizations: 117.
Take DOXORUBICIN Side Effects Survey or Share Your DOXORUBICIN Story. Read More Here.

Showing 1-75 of 257 Next >

Consumer or non-health professional from NORWAY reported DOXORUBICIN problem on Apr 04, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISOLONE, ETOPOSIDE, RITUXIMAB. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from NORWAY on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB. Patient recovered.

Consumer or non-health professional from NORWAY reported DOXORUBICIN problem on Apr 04, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: DAILY DOSE:50MG/M*2. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE SULPHATE, RITUXIMAB. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from NORWAY on Apr 04, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: DAILY DOSE:50MG/M*2. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISOLONE, ETOPOSIDE, VINCRISTINE SULPHATE, RITUXIMAB. Patient recovered.

Consumer or non-health professional from NORWAY reported DOXORUBICIN problem on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: DAILY DOSE:50MG/M*2. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE SULPHATE, RITUXIMAB. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 147.7 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, respiratory distress. DOXORUBICIN dosage: 54 MG. During the same period patient was treated with ETOPOSIDE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported DOXORUBICIN problem on Apr 11, 2007. Female patient, 63 years of age, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: aplasia. DOXORUBICIN dosage: unknown. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2007. Male patient, 43 years of age, was diagnosed with burkitt's lymphoma, acquired immunodeficiency syndrome and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, osteoporosis, spinal fracture. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, METHOTREXATE, PREDNISOLONE, HYDROCORTISONE ACETATE, RITONAVIR, SAQUINAVIR, VINCRISTINE. Patient recovered.

Consumer or non-health professional from ITALY reported DOXORUBICIN problem on Apr 09, 2007. Female patient, 25 years of age, was diagnosed with hodgkin's disease and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: carotid artery thrombosis. DOXORUBICIN dosage: unknown. During the same period patient was treated with BLEOMYCIN, VINBLASTINE SULPHATE, DACARBAZINE. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Apr 12, 2007. Male patient, 43 years of age, was diagnosed with burkitt's lymphoma, acquired immunodeficiency syndrome and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: back pain, blood cholesterol increased, blood triglycerides increased, osteonecrosis, osteoporosis, pain in extremity, spinal compression fracture, spinal fracture. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, HYDROCORTISONE, METHOTREXATE, PREDNISOLONE, RITONAVIR, SAQUINAVIR, VINCRISTINE. Patient was hospitalized. Patient recovered.

Physician from ROMANIA reported DOXORUBICIN problem on Apr 18, 2007. Female patient, weighting 152.1 lb, was diagnosed with breast cancer, metastases to bone and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: bronchospasm, stomatitis. DOXORUBICIN dosage: unknown. During the same period patient was treated with DOCETAXEL, PAMIDRONATE DI. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from NORWAY on Apr 18, 2007. Female patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

Health Professional from NORWAY reported DOXORUBICIN problem on Apr 18, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: immunodeficiency, infection in an immunocompromised host, pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from NORWAY on Apr 18, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: immunodeficiency, infection in an immunocompromised host, pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

Health Professional from NORWAY reported DOXORUBICIN problem on Apr 18, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from NORWAY on Apr 18, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

Health Professional from NORWAY reported DOXORUBICIN problem on Apr 18, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: immunodeficiency, infection in an immunocompromised host, pneumocystis jiroveci pneumonia. DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 20, 2007. Male patient, 43 years of age, was diagnosed with burkitt's lymphoma, acquired immunodeficiency syndrome, antifungal prophylaxis and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: back pain, blood cholesterol increased, blood triglycerides increased, osteonecrosis, osteoporosis, pain in extremity, spinal compression fracture, spinal fracture. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, METHOTREXATE, PREDNISOLONE, HYDROCORTISONE ACETATE, TRIMETHOPRIM, SULFAMETHOXAZOLE, RITONAVIR. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported DOXORUBICIN problem on Apr 23, 2007. Female patient, 54 years of age, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. DOXORUBICIN dosage: TEXT:93 MG. During the same period patient was treated with ENDOXAN. Patient recovered.

DOXORUBICIN problem was reported by a Physician from SWITZERLAND on May 10, 2007. Female patient, weighting 108.0 lb, was diagnosed with breast cancer metastatic and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: asthenia, haematotoxicity, haemoglobin decreased, leukopenia, neutropenia, pulmonary embolism. DOXORUBICIN dosage: unknown. Patient died on 03/07/2006.

Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on May 08, 2007. Female patient, weighting 138.0 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 125 increased, dysphagia, glossodynia, rash pruritic, skin disorder, stomatitis. DOXORUBICIN dosage: unknown. During the same period patient was treated with EFFEXOR, POTASSIUM ACETATE, VITAMIN B6, GLUCOSAMINE CHONDROITIN, AMMONIUM LACTATE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from SWITZERLAND on Apr 24, 2006. Female patient, weighting 116.8 lb, was diagnosed with breast cancer metastatic and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome. DOXORUBICIN dosage: unknown. During the same period patient was treated with CAPECITABINE, VINORELBINE, DEXAMETHASONE, NOVABAN, TAMOXIFEN CITRATE. Patient recovered.

Consumer or non-health professional from reported DOXORUBICIN problem on May 15, 2007. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: muscle twitching, progressive multifocal leukoencephalopathy, viral infection. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, VINCRISTINE, PREDNISONE, CHLORAMBUCIL, FLUDARABINE PHOSPHATE. Patient died.

DOXORUBICIN problem was reported by a Physician from UNITED STATES on May 16, 2007. Male patient, weighting 152.3 lb, was diagnosed with multiple myeloma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac disorder. DOXORUBICIN dosage: unknown. During the same period patient was treated with VELCADE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported DOXORUBICIN problem on May 17, 2007. Female patient, child 4 years of age, was diagnosed with neuroblastoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: no adverse effect. DOXORUBICIN dosage: unknown. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, CISPLATIN, VINCRISTINE SULPHATE, VINCRISTINE SULPHATE, VINCRISTINE SULPHATE, CARBOPLATIN. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from FRANCE on May 14, 2007. Male patient, 63 years of age, was diagnosed with neuroendocrine carcinoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, myocardial ischaemia, ventricular extrasystoles. DOXORUBICIN dosage: DAILY DOSE:37.8MG-FREQ:DAILY. During the same period patient was treated with ETOPOSIDE, ENDOXAN, CALCIDOSE, PREGABALIN, ARGININE, RIVOTRIL, VERAPAMIL, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Physician from CANADA reported DOXORUBICIN problem on May 22, 2007. Female patient, weighting 113.5 lb, was diagnosed with osteoporosis, arthralgia, dyspepsia, nausea and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophageal candidiasis. DOXORUBICIN dosage: 78MG TOTAL DOSE ADMINISTERED FROM 14.30 -16.20 ON 16-FEB-2007. During the same period patient was treated with TRABECTEDIN, ETIDRONATE DI, CALCIUM WITH VITAMIN D, ANTIPHLOGISTINE, TIGER BALM, ALGINIC ACID, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from FRANCE on May 15, 2007. Male patient, 24 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: disease recurrence, hepatitis b. DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, STEROIDS, PREDNISONE, LOPINAVIR, RITONAVIR, EFAVIRENZ, LAMIVUDINE. Patient recovered.

Physician from ITALY reported DOXORUBICIN problem on May 22, 2007. Female patient, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pain in extremity, vertigo, vomiting. DOXORUBICIN dosage: unknown. During the same period patient was treated with VELCADE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from KOREA, REPUBLIC OF on May 31, 2007. Male patient, weighting 172.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: ascites. DOXORUBICIN dosage: unknown. During the same period patient was treated with ELOXATIN. Patient was hospitalized. Patient died on 08/27/2006.

Health Professional from UNITED KINGDOM reported DOXORUBICIN problem on May 21, 2007. Male patient, 43 years of age, was diagnosed with burkitt's lymphoma, hiv infection and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, multiple fractures, osteonecrosis, osteoporosis, pathological fracture, spinal compression fracture, treatment noncompliance. DOXORUBICIN dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE, HYDROXYCORTISONE, CYTARABINE, RITONAVIR, SAQUINAVIR. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from ITALY on June 06, 2007. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with ovarian cancer, arrhythmia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, leukopenia, neutropenia, sepsis. DOXORUBICIN dosage: unknown. During the same period patient was treated with RYTHMOL. Patient was hospitalized. Patient died on 06/03/2007.

Health Professional from UNITED STATES reported DOXORUBICIN problem on June 08, 2007. Male patient, weighting 132.5 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: anaemia, dehydration, febrile neutropenia, white blood cell count decreased. DOXORUBICIN dosage: 33 MG. During the same period patient was treated with ESTRAMUSTINE, NIZORAL, VINBLASTINE SULPHATE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, weighting 217.4 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: fatigue, hyperhidrosis, neutropenia, pneumonia, pulmonary embolism, pyrexia, troponin increased. DOXORUBICIN dosage: 90 MG. During the same period patient was treated with CISPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DOXORUBICIN problem on June 05, 2007. Female patient, weighting 141.1 lb, was diagnosed with b-cell unclassifiable lymphoma high grade and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cardiac failure, haemolytic anaemia, methaemoglobinaemia. DOXORUBICIN dosage: unknown. During the same period patient was treated with MABTHERA, UROMITEXAN, ENDOXAN, FASTURTEC, HYDROCORTISONE HEMISUCCINATE, METHOTREXATE, CYTARABINE, ZOFRAN. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from JAPAN on May 31, 2007. Female patient was diagnosed with lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. DOXORUBICIN dosage: DAILY DOSE:72MG. During the same period patient was treated with RITUXAN, ENDOXAN, ONCOVIN, PREDONINE, KYTRIL, RESTAMIN, ACETAMINOPHEN, AMLODIN. Patient was hospitalized. Patient recovered.

Physician from ITALY reported DOXORUBICIN problem on June 06, 2007. Female patient, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: fungal infection, pain in extremity, vertigo, vomiting. DOXORUBICIN dosage: unknown. During the same period patient was treated with VELCADE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from CANADA on June 06, 2007. Female patient, weighting 113.5 lb, was diagnosed with ovarian cancer, osteoporosis, arthralgia, dyspepsia, nausea and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophageal candidiasis. DOXORUBICIN dosage: 78MG TOTAL DOSE ADMINISTERED FROM 14.30 -16.20 ON 16-FEB-2007. During the same period patient was treated with TRABECTEDIN, ETIDRONATE DI, CALCIUM WITH VITAMIN D, ANTIPHLOGISTINE, ALGINIC ACID, METOCLOPRAMIDE, ONDANSETRON. Patient was hospitalized. Patient recovered.

Health Professional from ITALY reported DOXORUBICIN problem on June 11, 2007. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with ovarian cancer, arrhythmia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, leukopenia, neutropenia, sepsis. DOXORUBICIN dosage: unknown. During the same period patient was treated with RYTHMOL. Patient was hospitalized. Patient died on 06/03/2007.

DOXORUBICIN problem was reported by a Health Professional from UNITED STATES on June 11, 2007. Female patient, 89 years of age, weighting 121.5 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, nausea, pneumonitis. DOXORUBICIN dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISONE, NEULASTA, CENTRUM, COREG. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DOXORUBICIN problem on June 11, 2007. Female patient, weighting 153.0 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting, white blood cell count increased. DOXORUBICIN dosage: unknown. During the same period patient was treated with TRABECTEDIN, NORVASC, EFFEXOR, NEURONTIN, ATIVAN, COLACE, SENOKOT, DETROL. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from UNITED STATES on June 18, 2007. Female patient, weighting 153.0 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting, white blood cell count increased. DOXORUBICIN dosage: unknown. During the same period patient was treated with TRABECTEDIN, NORVASC, EFFEXOR, NEURONTIN, ATIVAN, COLACE, SENOKOT, DETROL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on June 27, 2007. Male patient, weighting 219.4 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac failure congestive, cardiomyopathy, dilatation ventricular, ejection fraction decreased, hypertension, insomnia, left ventricular dysfunction, mitral valve incompetence. DOXORUBICIN dosage: 116 MG. During the same period patient was treated with GEMCITABINE, LISINIPRIL, POTASSIUM ACETATE, LASIX. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from SPAIN on June 27, 2006. Female patient, 65 years of age, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cyanosis, infusion related reaction. DOXORUBICIN dosage: unknown. During the same period patient was treated with ANTIEMETIC. Patient recovered.

Health Professional from AUSTRIA reported DOXORUBICIN problem on July 03, 2006. Female patient, weighting 154.3 lb, was diagnosed with breast cancer, depression, gastritis, insomnia, hypertonia, ascites and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, sepsis. DOXORUBICIN dosage: unknown. During the same period patient was treated with PAROXETINE, OXETACAINE, BROTIZOLAM, PANTOPRAZOL, CAPTOPRIL HYDROCHLOROTHIAZIDE, FUROSEMIDE. Patient was hospitalized. Patient died on 12/22/2005.

DOXORUBICIN problem was reported by a Physician from FRANCE on June 27, 2006. Male patient, 37 years of age, was diagnosed with multiple myeloma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: acute tonsillitis, agranulocytosis. DOXORUBICIN dosage: 50 MG/25 ML, INTRAVENOUS. During the same period patient was treated with VINCRISTINE SULPHATE, BORTEZOMIB, DEXAMETHASONE PHOSPHATE, CIFLOX, CEFTAZIDIME PENTAHYDRATE, AUGMENTIN, ARANESP. Patient died on 04/21/2006.

Physician from FRANCE reported DOXORUBICIN problem on June 26, 2006. Female patient, 49 years of age, weighting 211.6 lb, was diagnosed with ill-defined disorder and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, candida sepsis, cerebral haemorrhage, enterobacter sepsis, hyperthermia, inflammation, pyrexia. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, RITUXIMAB, METHOTREXATE, VINCRISTINE SULPHATE, OFLOXACIN, AMOXYCILLINE. Patient died.

DOXORUBICIN problem was reported by a Physician from FINLAND on July 11, 2006. Female patient, 68 years of age, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: sudden hearing loss. DOXORUBICIN dosage: unknown. Patient recovered.

Physician from ITALY reported DOXORUBICIN problem on July 11, 2006. Female patient, 57 years of age, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. DOXORUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Pharmacist from UNITED STATES on July 11, 2006. Female patient, 46 years of age, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac tamponade, dyspnoea, pericardial effusion, pleural effusion, treatment noncompliance. DOXORUBICIN dosage: unknown. During the same period patient was treated with TAXOTERE, CYTOXAN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on July 28, 2006. Male patient, weighting 30.42 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: tuberculosis. DOXORUBICIN dosage: 42.25 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from ITALY on July 13, 2006. Male patient, 62 years of age, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, atrial flutter, chills, diarrhoea, febrile neutropenia, weight decreased, white blood cell count decreased. DOXORUBICIN dosage: 100 MG DAILY IV. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, DEXAMETHASONE, NEUPOGEN, FLUCONAZOLE, LEVOFLOXACIN, VALACYCLOVIR, HALOPURINOL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DOXORUBICIN problem on July 21, 2006. Female patient, 61 years of age, weighting 176.4 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: palmar-plantar erythrodysaesthesia syndrome. DOXORUBICIN dosage: unknown. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, weighting 160.1 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. DOXORUBICIN dosage: 112 MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on Aug 02, 2006. Female patient, weighting 153.7 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count decreased. DOXORUBICIN dosage: 110 MG. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from JAPAN on July 20, 2006. Female patient, child 4 years of age, was diagnosed with lung neoplasm and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, multiple sclerosis, optic neuritis, recurrent cancer. DOXORUBICIN dosage: 160 MG/M*2. During the same period patient was treated with CISPLATIN, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, DACTINOMYCIN. Patient recovered.

Physician from FRANCE reported DOXORUBICIN problem on July 26, 2006. Female patient, 68 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, brain damage, cerebral atrophy. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, METHOTREXATE, RITUXIMAB. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from GERMANY on July 28, 2006. Female patient, 60 years of age, was diagnosed with anaemia of malignant disease and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: axillary vein thrombosis, catheter site related reaction, paget-schroetter syndrome, parathyroid disorder, swelling. DOXORUBICIN dosage: 95 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOCETAXEL, ARANESP. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on Aug 15, 2006. Female patient, weighting 200.4 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, white blood cell count increased. DOXORUBICIN dosage: 120 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from UNITED STATES on July 14, 2006. Female patient, child 9 years of age, was diagnosed with nephroblastoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant, solitary kidney secondary. DOXORUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, VINCRISTINE, DACTINOMYCIN. Patient recovered.

Health Professional from UNITED STATES reported DOXORUBICIN problem on Aug 10, 2006. Female patient, 67 years of age, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, leukocytosis. DOXORUBICIN dosage: unknown. During the same period patient was treated with PACLITAXEL, DEXAMETHASONE, CYCLOPHOSPHAMIDE, NEULASTA. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from FRANCE on Aug 09, 2006. Female patient, weighting 3.97 lb, was diagnosed with hodgkin's disease stage ii and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: apgar score low, bradycardia foetal, caesarean section, failed induction of labour, neonatal respiratory distress syndrome. DOXORUBICIN dosage: unknown. During the same period patient was treated with BLEOMYCIN, VINBLASTINE SULPHATE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported DOXORUBICIN problem on Aug 25, 2006. Male patient, 58 years of age, weighting 185.2 lb, was diagnosed with metastases to liver, gastrointestinal stromal tumour and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, heart rate decreased, hypertension, hypotension, procedural complication, syncope, transaminases increased. DOXORUBICIN dosage: unknown. During the same period patient was treated with LIPIODOL, METOCLOPRAMIDE, PANTOZOL, NORVASC, COSOPT, FOSINORM, LACTULOSE. Patient recovered.

DOXORUBICIN problem was reported by a Health Professional from UNITED STATES on Sept 08, 2006. Female patient, weighting 151.5 lb, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. DOXORUBICIN dosage: 60MG/ M2 Q2WEEKS- 4 CYCLE IV. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on Sept 14, 2006. Female patient, weighting 121.3 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: chills, neutropenia, pyrexia, syncope. DOXORUBICIN dosage: 38.5 MG. During the same period patient was treated with GEMCITABINE, VINBLASTINE SULPHATE. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Male patient, weighting 195.6 lb, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: gastritis, gastrointestinal disorder, leukopenia. DOXORUBICIN dosage: 42 MG. During the same period patient was treated with ESTRAMUSTINE, KETOCONAZOLE, VINBLASTINE SULPHATE, ALTACE, COUMADIN, CREATPR, HYDROCHLOROTHIAZDE, NAPROXEN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DOXORUBICIN problem on Sept 28, 2006. Female patient, weighting 110.9 lb, was diagnosed with desmoid tumour and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: myelitis transverse. DOXORUBICIN dosage: 40MG/M2 (60 MG) Q 3 WKS IV. During the same period patient was treated with DOXORUBICIN LIPOSOMALECTION, ONDANSETRON, DEXAMETHASONE, PEPCID. Patient was hospitalized and became disabled. Patient recovered.

DOXORUBICIN problem was reported by a Physician from ITALY on Sept 18, 2006. Male patient, 65 years of age, was diagnosed with hepatic neoplasm malignant and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, liver abscess, pyrexia. DOXORUBICIN dosage: 80 MG (FREQUENCY: ONCE), INTRAVENOUS. During the same period patient was treated with LIPIODOL, ATENOLOL, LASIX, ESOMEPRAZOLE, PORTOLAC, MEGACE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DOXORUBICIN problem on Sept 21, 2006. Female patient, 62 years of age, was diagnosed with ovarian cancer, essential hypertension and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, pemphigoid, skin lesion. DOXORUBICIN dosage: unknown. During the same period patient was treated with NIFEDIPINE, ZOFRAN. Patient was hospitalized. Patient recovered.

DOXORUBICIN problem was reported by a Physician from UNITED KINGDOM on Oct 02, 2006. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: jc virus infection, progressive multifocal leukoencephalopathy. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, VINCRISTINE, CHLORAMBUCIL, FLUDARABINE. Patient died.

Physician from ISRAEL reported DOXORUBICIN problem on Sept 27, 2006. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma stage iii, non-hodgkin's lymphoma stage iv and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: biopsy lung abnormal, computerised tomogram abnormal, cough, crepitations, dyspnoea, hypoxia, lung consolidation, lung infiltration, pneumonitis. DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, RITUXIMAB. Patient was hospitalized. Patient died.

DOXORUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Oct 02, 2006. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: demyelination, jc virus infection, muscle twitching, progressive multifocal leukoencephalopathy. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, VINCRISTINE, PREDNISONE, CHLORAMBUCIL, FLUDARABINE PHOSPHATE. Patient died.

Health Professional from UNITED KINGDOM reported DOXORUBICIN problem on Oct 02, 2006. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: brain scan abnormal, demyelination, jc virus infection, muscle twitching, progressive multifocal leukoencephalopathy. DOXORUBICIN dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOPHAMIDE, RITUXIMAB, VINCRISTINE, CHLORAMBUCIL, FLUDARABINE PHOSPHATE. Patient died.

DOXORUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 28, 2006. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: disease recurrence, jc virus infection, muscle twitching, progressive multifocal leukoencephalopathy. DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, CHLORAMBUCIL, FLUDARABINE. Patient died.

Consumer or non-health professional from UNITED KINGDOM reported DOXORUBICIN problem on Oct 06, 2006. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: progressive multifocal leukoencephalopathy. DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient died.

Showing 1-75 of 257 Next >

Ask Our Patient Community about DOXORUBICIN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine)